Compare GSK plc (GSK) vs Lufax Holding Ltd (LU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Lufax Holding Ltd — how do they compare? GSK plc trades at $50.5 (market cap $102.60B), while Lufax Holding Ltd trades at $1.56 (market cap $2.41B). The key difference: GSK plc is far larger — about 42.6× Lufax Holding Ltd's market cap, and GSK plc pays a 3.57% dividend while Lufax Holding Ltd pays none. Which is the better fit depends on your goals.
| GSK | LU | |
|---|---|---|
Market Cap | $102.60B | $2.41B |
Sector | Health | Technology |
52-Week High | $61.18 | $4.40 |
52-Week Low | $38.22 | $1.23 |
Enterprise Value | $123.04B | — |
Dividend Yield | 3.57% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Lufax Holding Ltd
Lufax Holding Ltd is a leading financial technology (fintech) platform in China. The company operates a technology-driven personal financial services platform that offers a wide range of loans and wealth management products to its users. Lufax primarily serves the rapidly growing wealth and consumption needs of China’s mass affluent and affluent populations through a combination of its digital platform and an extensive offline network.
Read more on LU →
